Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28,694,438
-
Total 13F shares
-
156,046
-
Share change
-
+36,870
-
Total reported value
-
$230,527
-
Price per share
-
$1.47
-
Number of holders
-
12
-
Value change
-
+$54,950
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q4 2023
As of 31 Dec 2023,
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,046 shares.
The largest 10 holders included
CAPTRUST FINANCIAL ADVISORS, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, VANGUARD GROUP INC, STATE STREET CORP, Creative Planning, IFP Advisors, Inc, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and Qube Research & Technologies Ltd.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.